Supplementary Figure S1 from ACYP2 Induces Temozolomide Resistance in Glioblastoma by Promoting PARP1-Mediated DNA Damage Repair
Abstract
Supplementary Figure S1. Representative phase-contrast images of neurospheres treated with 100 μM TMZ for 6 days.
Fields of Study & Subjects
PARP inhibition in cancer therapy
Glioma Diagnosis and Treatment
Telomeres
Telomerase
and Senescence
Publication details
- Publication date
- 2 January 2026